Found: 92
Select item for more details and to access through your institution.
Phase II clinical trial of nab‐paclitaxel plus cisplatin plus gemcitabine (NABPLAGEM) in patients with untreated advanced pancreatic cancer.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 12, p. 1, doi. 10.1002/cam4.7412
- By:
- Publication type:
- Article
Magnetic resonance imaging of tumor response to stroma-modifying pegvorhyaluronidase alpha (PEGPH20) therapy in early-phase clinical trials.
- Published in:
- Scientific Reports, 2024, v. 11, n. 1, p. 1, doi. 10.1038/s41598-024-62470-9
- By:
- Publication type:
- Article
Advanced glycation end product (AGE) targeting antibody SIWA318H is efficacious in preclinical models for pancreatic cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-44211-6
- By:
- Publication type:
- Article
Advanced glycation end product (AGE) targeting antibody SIWA318H is efficacious in preclinical models for pancreatic cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-44211-6
- By:
- Publication type:
- Article
Can Imaging Using Radiomics and Fat Fraction Analysis Detect Early Tissue Changes on Historical CT Scans in the Regions of the Pancreas Gland That Subsequently Develop Adenocarcinoma?
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 5, p. 941, doi. 10.3390/diagnostics13050941
- By:
- Publication type:
- Article
Increasing Stress to Induce Apoptosis in Pancreatic Cancer via the Unfolded Protein Response (UPR).
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 1, p. 577, doi. 10.3390/ijms24010577
- By:
- Publication type:
- Article
Role of 3D Volumetric and Perfusion Imaging for Detecting Early Changes in Pancreatic Adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 12, p. 1, doi. 10.3389/fonc.2021.678617
- By:
- Publication type:
- Article
Analysis of the Role of Plasma 25‐Hydroxyvitamin D Levels in Survival Outcomes in Patients from the Phase III MPACT Trial of Metastatic Pancreatic Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e704, doi. 10.1002/onco.13645
- By:
- Publication type:
- Article
Analysis of recurrently protected genomic regions in cell-free DNA found in urine.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 581, p. 1, doi. 10.1126/scitranslmed.aaz3088
- By:
- Publication type:
- Article
Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pre-Diagnostic Period: Implications for Early Detection.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.596931
- By:
- Publication type:
- Article
Triptolide targets super-enhancer networks in pancreatic cancer cells and cancer-associated fibroblasts.
- Published in:
- Oncogenesis, 2020, v. 9, n. 11, p. N.PAG, doi. 10.1038/s41389-020-00285-9
- By:
- Publication type:
- Article
Correction to: Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions.
- Published in:
- Genome Medicine, 2020, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13073-020-00776-9
- By:
- Publication type:
- Article
Dose–response assessment by quantitative MRI in a phase 1 clinical study of the anti-cancer vascular disrupting agent crolibulin.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-71246-w
- By:
- Publication type:
- Article
Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 4, p. 636, doi. 10.1007/s10637-018-0668-8
- By:
- Publication type:
- Article
First‐in‐Human Phase I Study of MBC‐11, a Novel Bone‐Targeted Cytarabine‐Etidronate Conjugate in Patients with Cancer‐Induced Bone Disease.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 303, doi. 10.1634/theoncologist.2018-0707
- By:
- Publication type:
- Article
Oncology Navigation: A Virtual Model to Promote Self-Advocacy in the Cancer Continuum.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2019, v. 10, n. 1, p. 12
- By:
- Publication type:
- Article
A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab‐Paclitaxel and Gemcitabine in Advanced Solid Tumors.
- Published in:
- Oncologist, 2019, v. 24, n. 1, p. 14, doi. 10.1634/theoncologist.2017-0665
- By:
- Publication type:
- Article
Safety, pharmacokinetics, and preliminary efficacy of E6201 in patients with advanced solid tumours, including melanoma: results of a phase 1 study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase I dose escalation study of NMS-1286937, an orally available Polo-Like Kinase 1 inhibitor, in patients with advanced or metastatic solid tumors.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 1, p. 85, doi. 10.1007/s10637-017-0491-7
- By:
- Publication type:
- Article
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours.
- Published in:
- 2018
- By:
- Publication type:
- corrected article
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours.
- Published in:
- British Journal of Cancer, 2018, v. 118, n. 2, p. 153, doi. 10.1038/bjc.2017.327
- By:
- Publication type:
- Article
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Inhibition of ROCK1 kinase modulates both tumor cells and stromal fibroblasts in pancreatic cancer.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0183871
- By:
- Publication type:
- Article
Clinical study of genomic drivers in pancreatic ductal adenocarcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
<sup>18</sup>F-FDG PET/CT response in a phase 1/2 trial of nab-paclitaxel plus gemcitabine for advanced pancreatic cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Letter to the Editor Re: Ahn DH, Krishna K, Blazer M, et al. “A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis.” Ther Adv Med Oncol https://doi.org/10.1177/1758834016676011
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 6, p. 441, doi. 10.1177/1758834017699772
- By:
- Publication type:
- Article
Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis.
- Published in:
- British Journal of Cancer, 2017, v. 116, n. 10, p. 1247, doi. 10.1038/bjc.2017.67
- By:
- Publication type:
- Article
Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The National Cancer Institute R25 Cancer Education Grants Program: A Workshop Report.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Case report: whole exome sequencing of primary cardiac angiosarcoma highlights potential for targeted therapies.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Blocking Nerve Growth Factor Signaling Reduces the Neural Invasion Potential of Pancreatic Cancer Cells.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0165586
- By:
- Publication type:
- Article
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 2, p. 1, doi. 10.1093/jnci/dju413
- By:
- Publication type:
- Article
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Prognostic Factors ofSurvival in a Randomized Phase III Trial (MPACT) of Weekly nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Pancreatic Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 2, p. 143, doi. 10.1634/theoncologist.2014-0394
- By:
- Publication type:
- Article
Whole genome sequencing reveals potential targets for therapy in patients with refractory KRAS mutated metastatic colorectal cancer.
- Published in:
- BMC Medical Genomics, 2014, v. 7, n. 1, p. 3, doi. 10.1186/1755-8794-7-36
- By:
- Publication type:
- Article
STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma.
- Published in:
- Genome Medicine, 2014, v. 6, n. 1, p. 1, doi. 10.1186/gm526
- By:
- Publication type:
- Article
A Pilot Study Using Next-Generation Sequencing in Advanced Cancers: Feasibility and Challenges.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0076438
- By:
- Publication type:
- Article
Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs.
- Published in:
- BMC Genomics, 2013, v. 14, n. 1, p. 1, doi. 10.1186/1471-2164-14-302
- By:
- Publication type:
- Article
Cancer of the ampulla of Vater: analysis of the whole genome sequence exposes a potential therapeutic vulnerability.
- Published in:
- Genome Medicine, 2012, v. 4, n. 7, p. 1, doi. 10.1186/gm357
- By:
- Publication type:
- Article
Paired Tumor and Normal Whole Genome Sequencing of Metastatic Olfactory Neuroblastoma.
- Published in:
- PLoS ONE, 2012, v. 7, n. 5, p. 1, doi. 10.1371/journal.pone.0037029
- By:
- Publication type:
- Article
Down-Regulation of Yes Associated Protein 1 Expression Reduces Cell Proliferation and Clonogenicity of Pancreatic Cancer Cells.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0032783
- By:
- Publication type:
- Article
Specification, annotation, visualization and simulation of a large rule-based model for ERBB receptor signaling.
- Published in:
- BMC Systems Biology, 2012, v. 6, n. 1, p. 107, doi. 10.1186/1752-0509-6-107
- By:
- Publication type:
- Article
Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome.
- Published in:
- Dermatology Reports, 2011, v. 3, n. 3, p. 125, doi. 10.4081/dr.2011.e55
- By:
- Publication type:
- Article
Perineural invasion and associated pain in pancreatic cancer.
- Published in:
- 2011
- By:
- Publication type:
- journal article